Stock listing

NASDAQ:RNTX Rein Therapeutics, Inc. Stock

Home listing (NASDAQ) of Rein Therapeutics, Inc.

Follow Rein Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:RNTX

$0.67 USD -0.06 (-7.8%)

Close on Oct 30, 2026

Past year -56.8% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.66 – $0.70 USDOct 30, 2026
Volume
121,310 sharesOct 30, 2026
Market cap
$57.80M USDAt the close on Oct 30, 2026 · price × 86.27M shares outstanding
52-week range
$0.54 – $2.18 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$320,853 USDMedian day 340,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Rein Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RNTX · Home$0.67 USD-0.057 (-7.8%)121,310$0.70$0.70$0.66$0.727Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:RNTX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.67-0.057-7.8%$0.70$0.70$0.66121,310
$0.727+0.012+1.7%$0.701$0.75$0.677187,766
$0.715+0.01+1.5%$0.697$0.741$0.66389,704
$0.704+0.121+20.7%$0.60$0.708$0.59620,312
$0.583+0.001+0.2%$0.57$0.609$0.56393,786
$0.582-0.02-3.3%$0.595$0.612$0.572331,300
$0.602-0.023-3.7%$0.62$0.624$0.59305,200
$0.625+0.03+5.0%$0.607$0.65$0.595266,100
$0.595+0.043+7.8%$0.545$0.607$0.543296,400
$0.552-0.038-6.4%$0.58$0.615$0.552502,200
$0.59-0.038-6.1%$0.613$0.622$0.57372,000
$0.628+0.042+7.2%$0.60$0.666$0.5511,372,900
$0.586-0.169-22.4%$0.755$0.755$0.541,143,400
$0.755-0.03-3.8%$0.777$0.777$0.75142,500
$0.785-0.009-1.1%$0.77$0.788$0.75108,100
$0.794+0.025+3.3%$0.761$0.81$0.761307,500
$0.769-0.02-2.5%$0.784$0.784$0.746477,600
$0.789-0.036-4.4%$0.80$0.817$0.78447,000
$0.8250.000.0%$0.825$0.834$0.809185,600
$0.825+0.024+3.0%$0.815$0.87$0.81336,100
$0.801-0.051-6.0%$0.85$0.863$0.78480,500
$0.852+0.048+6.0%$0.804$0.899$0.7591,108,000
$0.804+0.014+1.8%$0.80$0.826$0.762419,000
$0.79+0.069+9.6%$0.72$0.81$0.72388,400
$0.721-0.027-3.6%$0.763$0.79$0.72162,800
$0.748+0.004+0.5%$0.741$0.82$0.73112,800
$0.744-0.026-3.4%$0.77$0.785$0.715296,300
$0.77-0.025-3.1%$0.79$0.817$0.77441,400
$0.7950.000.0%$0.807$0.821$0.7987,100
$0.795-0.005-0.6%$0.811$0.815$0.79178,200
$0.80+0.011+1.4%$0.792$0.82$0.78492,500
$0.789+0.087+12.4%$0.715$0.79$0.703262,700
$0.702-0.006-0.8%$0.71$0.74$0.70266,400
$0.708-0.083-10.5%$0.784$0.79$0.70556,100
$0.791+0.006+0.8%$0.801$0.845$0.75346,800
$0.785+0.004+0.5%$0.799$0.813$0.77295,600
$0.781-0.047-5.7%$0.82$0.835$0.772240,800
$0.828-0.035-4.1%$0.88$0.88$0.822265,300
$0.863-0.026-2.9%$0.93$0.96$0.85760,300
$0.889+0.045+5.3%$0.92$0.92$0.85984,800
$0.844+0.069+8.9%$0.79$0.87$0.79568,000
$0.775+0.022+2.9%$0.76$0.791$0.736489,100
$0.753+0.003+0.4%$0.749$0.765$0.729344,300
$0.75-0.012-1.6%$0.77$0.776$0.741546,100
$0.762-0.021-2.7%$0.788$0.788$0.762259,000
$0.783-0.017-2.1%$0.792$0.811$0.783136,500
$0.800.000.0%$0.81$0.824$0.78324,700
$0.800.000.0%$0.804$0.822$0.771276,754
$0.80-0.018-2.2%$0.82$0.824$0.77463,562
$0.818+0.024+3.0%$0.80$0.855$0.771580,000
$0.794+0.002+0.3%$0.856$0.877$0.7752,489,200
$0.792+0.022+2.9%$0.80$0.819$0.77352,900
$0.77-0.071-8.4%$0.849$0.877$0.77525,300
$0.841+0.035+4.3%$0.82$0.86$0.775296,600
$0.806+0.018+2.3%$0.81$0.817$0.76216,100
$0.788-0.017-2.1%$0.81$0.83$0.78217,500
$0.805-0.012-1.5%$0.823$0.823$0.80479,500
$0.817+0.023+2.9%$0.816$0.855$0.769201,420
$0.794-0.024-2.9%$0.833$0.838$0.759399,035
$0.818+0.029+3.7%$0.789$0.823$0.769361,300
$0.789+0.075+10.5%$0.72$0.789$0.72206,100
$0.714-0.05-6.5%$0.765$0.78$0.6941,101,100
$0.764+0.018+2.4%$0.76$0.808$0.75483,800
$0.746+0.009+1.2%$0.74$0.764$0.725139,300
$0.737-0.031-4.0%$0.809$0.81$0.726391,700
$0.768+0.01+1.3%$0.754$0.83$0.754182,100
Ticker
NASDAQ:RNTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Sep 4, 2026

Closed $0.889 (+5.3%) on Sep 4, 2026

Rein Therapeutics to Present at Upcoming September Investor Conferences

Sep 3, 2026

Closed $0.889 (+5.3%) on Sep 4, 2026

Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis

Aug 20, 2026

Closed $0.794 (+0.3%) on Aug 20, 2026

Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 14, 2026

Closed $0.806 (+2.3%) on Aug 14, 2026

Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications

Aug 4, 2026

Closed $0.764 (+2.4%) on Aug 4, 2026

Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries

Jul 21, 2026

Closed $0.895 (+6.0%) on Jul 21, 2026

Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

Jun 11, 2026

Closed $0.926 (+0.7%) on Jun 11, 2026

Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option

May 18, 2026

Closed $1.04 (-1.0%) on May 18, 2026

Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Apr 30, 2026

Closed $1.36 (+6.3%) on Apr 30, 2026

Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis

Apr 29, 2026

Closed $1.28 (-12.1%) on Apr 29, 2026

All Rein Therapeutics, Inc. news

Decks

Rein Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 104 in all · newest Sep 4, 2026 · oldest 2020
Decks
4 decks · latest September 2026

Where Rein Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RNTX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:RNTXBOATSUnited StatesUSD
Tradegate:015ATradegateGermanyEUR

Log in to ask 6ix AI your own questions about Rein Therapeutics, Inc.